Close
Help





JOURNAL

Clinical Medicine Insights: Oncology

State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia

Submit a Paper


Clinical Medicine Insights: Oncology 2012:6 165-178

Review

Published on 19 Mar 2012

DOI: 10.4137/CMO.S6201


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Oncology

The Editor-in-Chief has endorsed this article

The article is a clear and concise review of major updates in the diagnosis, prognosis and therapy of CLL.

Abstract

The management of chronic lymphocytic leukemia (CLL) has evolved dramatically in the last decade. For the first time, clinical intervention has been shown to alter the natural history of the disease. Considerable efforts are focussing on better patient selection and response prediction, and it is expected that the publication of the first 200 CLL genomes will spark new insights into risk stratification of CLL patients. Besides, many new agents are being evaluated on their own and in combination therapy in early and late Phase clinical studies. Here, we provide a general clinical introduction into CLL including diagnosis and prognostic markers followed by a summary of the current state-of-the-art treatment. We point to areas of continued clinical research in particular for patients with co-morbidities and highlight the challenges in managing refractory disease.



Downloads

PDF  (994.23 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML





Quick Links


New article and journal news notification services